103 results
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
Exhibit 99.1
FOR IMMEDIATE RELEASE
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive … announced key leadership changes, including the appointment of Hugh O’Dowd, the Company’s current President, as the Company’s Chief Executive Officer
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm
in senior leadership roles with leading pharmaceutical companies –
BOCA RATON, Fla. – August 8, 2021 – TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative … throughout their life cycles from reproductive health through menopause. I look forward to working with the TherapeuticsMD leadership team and its
8-K
EX-99.2
TXMD
TherapeuticsMD Inc
20 Feb 20
TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results
6:57am
of experience in pharmaceutical sales leadership ▪ Experience in large and small pharmaceutical companies including Pfizer, Sunovion, Alder - Bio ▪ Have … Commercial Leadership Team Mike Steelman – Market Access Lead ▪ Senior leader access positions at Pfizer and Sanofi with United States and International
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
3 Mar 20
Regulation FD Disclosure
7:00am
Senior Sales Leader with 29 years of experience in pharmaceutical sales leadership ▪ Experience in large and small pharmaceutical companies including … organizations Build out of Commercial Expertise Commercial Leadership Team Mike Steelman – Market Access Lead ▪ Senior leader access positions at Pfizer
8-K/A
EX-99.1
TXMD
TherapeuticsMD Inc
16 Nov 21
Results of Operations and Financial Condition
6:30am
is a first-class professional with proven leadership and entrepreneurial skills and deep industry knowledge, having held leadership positions at both … wants to thank you for your leadership in founding the company and launching a portfolio of 3 innovative and well-differentiated therapies
8-K
EX-99.1
y3hjohsygs96 18
12 Sep 22
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
7:01am
8-K
a3iq8jla hx1p9c
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
yu5f9n 4s6
17 May 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
xe9p9pn ulp6zdc
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.2
ev8t1z al4tt7ljgp7l8
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.1
su6yl5x2
17 May 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
zv1zs2xq
2 Mar 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
vryk 9tzq
18 Dec 13
Therapeuticsmd Names Randall S. Stanicky to Board of Directors
12:00am
8-K
EX-99.1
0byeff7mzy4
14 Aug 23
TherapeuticsMD Announces Second Quarter 2023 Financial Results
7:15am